JUST IN: Regulators approve first drug treatment for obstructive sleep apnea 

  U.S regulators have approved the first drug treatment for moderate to severe obstructive sleep apnea (OSA) in adults with obesity. The U.S Food and Drug Administration (FDA) on Friday, December 20 said that Zepbound (tirzepatide) will be used in combination with a reduced-calorie diet and increased physical activity. “Today’s approval marks the first drug treatment
The post Regulators approve first drug treatment for obstructive sleep apnea appeared first on TV47 Digital. Read More